Rare diseases
Investigational molecules
Locations
22 Boulevard Benoni Goullin, 44200 Nantes, France
OSE Immunotherapeutics supports clinical research in advanced solid tumours and lymphomas, with attention to patients whose disease has progressed after prior treatment. The sponsor’s portfolio includes studies of immune-based cancer therapies across a broad range of oncology settings.
Research activity in this area reflects a focus on difficult-to-treat malignancies in Europe and other active international sites.
OSE Immunotherapeutics runs clinical trials in conditions such as Squamous cell carcinoma of lung, Non-small cell lung cancer, Non-small cell lung cancer stage IV, Lymphoma, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumBelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
